More News! 18 Dec 2019
French Biotech Raises €20M to Treat Cannabis Addiction Without Side Effects
Bordeaux-based Aelis Farma will use €20M in fresh funding to develop a new treatment for cannabis addiction and cannabis-induced psychosis, as well as a therapy for cognitive deficits in Down’s syndrome. The funding consists of €11M from a financing round coming mostly from regional investors, in addition to €9M raised through research grants. The […]